1. Home
  2. AA vs BMRN Comparison

AA vs BMRN Comparison

Compare AA & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alcoa Corporation

AA

Alcoa Corporation

N/A

Current Price

$39.73

Market Cap

13.0B

Sector

Industrials

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$57.23

Market Cap

12.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AA
BMRN
Founded
1888
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0B
12.3B
IPO Year
2016
1999

Fundamental Metrics

Financial Performance
Metric
AA
BMRN
Price
$39.73
$57.23
Analyst Decision
Buy
Buy
Analyst Count
14
28
Target Price
$54.59
★ $90.78
AVG Volume (30 Days)
★ 4.1M
2.4M
Earning Date
10-15-2026
11-02-2026
Dividend Yield
★ 0.99%
N/A
EPS Growth
★ 1580.77
N/A
EPS
★ 4.95
0.14
Revenue
★ $12,831,000,000.00
$1,313,646,000.00
Revenue This Year
$14.30
$20.05
Revenue Next Year
$1.35
$14.91
P/E Ratio
★ $8.18
$405.29
Revenue Growth
7.87
★ 17.62
52 Week Low
$35.12
$49.26
52 Week High
$84.38
$70.98

Technical Indicators

Market Signals
Indicator
AA
BMRN
Relative Strength Index (RSI) 45.73 50.38
Support Level $37.95 $53.19
Resistance Level $44.28 $58.39
Average True Range (ATR) 1.39 1.82
MACD 0.28 0.31
Stochastic Oscillator 38.96 70.56

Price Performance

Historical Comparison
AA
BMRN

About AA Alcoa Corporation

Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: